Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

BUY
$0.62 - $0.87 $7,261 - $10,189
11,712 New
11,712 $7,000
Q2 2022

Aug 11, 2022

SELL
$1.65 - $3.13 $5,628 - $10,676
-3,411 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$2.1 - $3.54 $7,163 - $12,074
3,411 New
3,411 $10,000
Q4 2021

Feb 10, 2022

SELL
$3.04 - $6.01 $6,417 - $12,687
-2,111 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$5.67 - $12.54 $11,969 - $26,471
2,111 New
2,111 $15,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.